Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PARKSEQ

Financiado

Single-cell sequencing analysis of striatal gene regulatory networks in Parkinso...

Single-cell sequencing analysis of striatal gene regulatory networks in Parkinson's disease Parkinson’s disease (PD) is the fastest growing Neurodegenerative disorder, currently affecting an estimate of 7 to 10 million people worldwide. The disease is characterized by the loss of dopaminergic neurons in the substantia ni... ver más

31/08/2026

UCA

165K€

Presupuesto del proyecto: 165K€

Líder del proyecto

UNIVERSIDAD DE CÁDIZ No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 1444

Ver 2 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-05-10

HORIZON-MSCA-2022-PF-01-01: MSCA Postdoctoral Fellowships 2022 ExpectedOutcome:

I+D

Cerrada hace 2 años

0% 100%

2 Participantes

UCA

165.31K€ | Lider

STOCKHOLMS UNIVERSITET

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PID2019-109046GA-I00 REDES GENETICAS REGULADORAS EN LA ENFERMEDAD DE PARKINSON 143K€ Cerrado

oxDOPAMINE Unraveling the mystery of preferential degeneration of midbr... 2M€ Cerrado

SAF2013-47939-R IDENTIFICACION DE GENES IMPLICADOS EN ENFERMEDAD DE PARKINSO... Cerrado

Dementia DNA rEpair impaired Mice with accElerated Neurodegeneration... 150K€ Cerrado

BFU2011-25734 ESTUDIO DE ENFEREMEDADES NEUROLOGICAS MEDIANTE EL USO DE DRO... 92K€ Cerrado

SAF2009-10434 ANALISIS GENETICO DE ENFERMEDAD DE PARKINSON 387K€ Cerrado

Duración del proyecto: 39 meses Fecha Inicio: 2023-05-10
Fecha Fin: 2026-08-31

Líder del proyecto

UNIVERSIDAD DE CÁDIZ No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 1444

Presupuesto del proyecto 165K€

Descripción del proyecto Parkinson’s disease (PD) is the fastest growing Neurodegenerative disorder, currently affecting an estimate of 7 to 10 million people worldwide. The disease is characterized by the loss of dopaminergic neurons in the substantia nigra and the accumulation of protein aggregates in the remaining ones. The loss of these cells leads to a dopamine deficit in the striatum which causes the motor symptoms characteristic of PD and the general malfunction of the neuronal circuitry in the basal ganglia. The existing treatment for PD is dopamine replacement therapy with levodopa. This drug alleviates the motor symptoms but has a number of side effects, loses efficacy with time and does not address the cognitive decline caused by PD. In order to gain a better understanding of the disease and open new paths towards an effective treatment, the PARKSEQ project will use the latest advanced in single-cell RNA sequencing and in situ hybridization to determine which cell-type specific gene regulatory networks (GRNs) are affected by PD in the striatum. To this end, I will use single-cell RNA sequencing (scRNA-seq) to study post-mortem human striatum samples from PD and control subjects, under the supervision and guidance of Ana Muñoz, a leading expert in PD and scRNA-seq studies. I will draw from my experience in Bioinformatics and in single cell data analysis to determine the cell types and subtypes existing in the human striatum. On each subtype, I will establish which genes are differentially expressed and, considering their co-expression, I will formulate putative altered GRNs. Then, during a secondment period, I will join Mats Nilsson laboratory to validate the scRNA-seq findings using in situ hybridization. Dr. Nilsson has advanced this technique making it possible to use verify the presence of over 100 genes simultaneously on intact tissue slices. This will enable me to verify the PD-induced alterations in the GRNs suggested by the scRNA-seq data.

Conecta tu I+D

Entra hoy

¿Olvidó su contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores